| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.0M | — | +2.1% |
| R&D Expense | $38.0M | — | -15.1% |
| SG&A Expense | $23.5M | — | -13.6% |
| Operating Income | -$58.4M | — | +15.2% |
| Pre-tax Income | -$48.4M | — | -22.6% |
| Net Income | -$48.4M | — | -22.6% |
| EPS (Basic) | -$0.40 | — | -17.6% |
| EPS (Diluted) | -$0.40 | — | -17.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $457.6M | -6.6% | -38.9% |
| Short-term Investments | $178.5M | +22.1% | +197.2% |
| Current Assets | $658.0M | -2.6% | -19.5% |
| Total Assets | $732.6M | -4.8% | -10.5% |
| Current Liabilities | $67.4M | -21.4% | +64.8% |
| Total Liabilities | $67.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$30.6M | — | +16.1% |
| Investing Cash Flow | -$11.5M | — | -503.1% |
| Financing Cash Flow | $11.1M | — | +69.7% |
| +64.2% |
| Stockholders' Equity | $665.2M | -2.7% | -14.4% |